Jeantet advises Getinge on the contemplated acquisition of Fluoptics, a leader in fluorescence imaging as an aid to surgery
Paris, 3 May 2022 – Jeantet has advised the Swedish listed global medical technology company Getinge AB (publ), with respect to the contemplated acquisition via its French subsidiary Getinge Infection Control SAS of 100% of the shares and voting rights of Fluoptics SAS a leader in fluorescence imaging as an aid to surgery. The transaction […]
Paris | CORPORATE – M&A – PRIVATE EQUITY | TECH & DATA | FINANCING | REAL ESTATE